A Look At CBIZ (CBZ) Valuation After A Steep One Year Share Price Decline

CBIZ stock moves and recent performance context

CBIZ (CBZ) has drawn fresh attention after recent share price moves, with the stock up around 1.7% on the day but down over the past week and month, while still positive over the past 3 months.

See our latest analysis for CBIZ.

That 1-day share price gain sits against a much weaker backdrop, with the year-to-date share price return down about 43% and the 1-year total shareholder return down around 61%, signalling fading momentum despite a modest 90-day share price recovery.

If this kind of volatility has you looking beyond a single stock, it may be a good moment to broaden your watchlist with 19 top founder-led companies

With CBIZ stock down sharply over the past year and trading at a discount to analyst targets and some valuation models, the key question is whether this reset reflects an undervalued opportunity or a market that is already pricing in future growth.

Most Popular Narrative: 33.1% Undervalued

At a last close of $28.92 versus a narrative fair value of $43.25, the current pricing sits well below what the prevailing narrative implies for CBIZ.

The Marcum acquisition has significantly expanded CBIZ's client base, increased scale, and strengthened capabilities in core tax, accounting, and advisory services, enabling the firm to leverage cross-selling, deepen client relationships, and improve its competitive position in target middle-market segments; this is expected to fuel higher future revenue growth and structural margin expansion as integration synergies are realized.

Read the complete narrative.

Curious what kind of revenue trajectory, margin lift and future P/E multiple have to come together to support that gap between price and fair value? The full narrative lays out a tight set of assumptions on growth, profitability and valuation that go well beyond simple year-ahead earnings guesses.

Result: Fair Value of $43.25 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, pricing pressure and higher leverage after the Marcum deal could still challenge margin ambitions and make earnings more sensitive to any slowdown in nonrecurring work.

Find out about the key risks to this CBIZ narrative.

Next Steps

With that mix of pressure and potential in mind, it makes sense to review the full picture for yourself and move quickly while sentiment is still unsettled. You can start with the 5 key rewards and 2 important warning signs

Looking for more investment ideas?

If CBIZ is on your radar, do not stop there. Use this momentum to widen your opportunity set and pressure test your current watchlist against fresh ideas.

• Target stability by scanning 66 resilient stocks with low risk scores that focus on resilient companies with lower risk profiles and more predictable financial characteristics.
• Hunt for quality at a discount through screener containing 22 high quality undiscovered gems that highlight lesser-known businesses with solid fundamentals the market might be overlooking.
• Strengthen your core holdings with solid balance sheet and fundamentals stocks screener (45 results) that spotlight companies backed by healthier balance sheets and more robust financial footing.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com